Hill Top Research Report issue

For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Cincinnati OH United States (1947)
Status: Acquired by Cliantha Research Limited (2011)

Organization Overview

First Clinical Trial
2005
NCT00858481
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 4 Trials (2)

buprenorphine (1 trial)

naloxone (narcan) (1 trial)

Drugs in Phase 3 Trials (4)

avobenzone (shade uvaguard) (1 trial)

ecamsule (Mexoryl SX) (1 trial)

octocrylene (1 trial)

titanium (1 trial)

Drugs in Phase 2 Trials (4)

3804-250a (2 trials)

3804-291 (1 trial)

spinosad (natroba) (5 trials)

Thimerosal (1 trial)

Drugs in Phase 1 Trials (1)

sodium chloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Common Cold (Phase 2)

Dermatitis, Photoallergic (Phase 1)

Herpes Labialis (Phase 2)

Herpes Simplex (Phase 2)

Lice Infestations (Phase 2)

Opioid-Related Disorders (Phase 4)

Stomatitis, Herpetic (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 10
  • # of Trial APIs: 11